Back to Search
Start Over
Cisplatin Resistance and Redox-Metabolic Vulnerability: A Second Alteration
- Source :
- International Journal of Molecular Sciences, International Journal of Molecular Sciences, Vol 22, Iss 7379, p 7379 (2021)
- Publication Year :
- 2021
- Publisher :
- MDPI, 2021.
-
Abstract
- The development of drug resistance in tumors is a major obstacle to effective cancer chemotherapy and represents one of the most significant complications to improving long-term patient outcomes. Despite early positive responsiveness to platinum-based chemotherapy, the majority of lung cancer patients develop resistance. The development of a new combination therapy targeting cisplatin-resistant (CR) tumors may mark a major improvement as salvage therapy in these patients. The recent resurgence in research into cellular metabolism has again confirmed that cancer cells utilize aerobic glycolysis (“the Warburg effect”) to produce energy. Hence, this observation still remains a characteristic hallmark of altered metabolism in certain cancer cells. However, recent evidence promotes another concept wherein some tumors that acquire resistance to cisplatin undergo further metabolic alterations that increase tumor reliance on oxidative metabolism (OXMET) instead of glycolysis. Our review focuses on molecular changes that occur in tumors due to the relationship between metabolic demands and the importance of NAD+ in redox (ROS) metabolism and the crosstalk between PARP-1 (Poly (ADP ribose) polymerase-1) and SIRTs (sirtuins) in CR tumors. Finally, we discuss a role for the tumor metabolites of the kynurenine pathway (tryptophan catabolism) as effectors of immune cells in the tumor microenvironment during acquisition of resistance in CR cells. Understanding these concepts will form the basis for future targeting of CR cells by exploiting redox-metabolic changes and their consequences on immune cells in the tumor microenvironment as a new approach to improve overall therapeutic outcomes and survival in patients who fail cisplatin.
- Subjects :
- 0301 basic medicine
Kynurenine pathway
QH301-705.5
Poly (ADP-Ribose) Polymerase-1
Review
Catalysis
Inorganic Chemistry
03 medical and health sciences
0302 clinical medicine
Immune system
oxidative metabolism
Neoplasms
Tumor Microenvironment
Medicine
Humans
Sirtuins
Glycolysis
Biology (General)
Physical and Theoretical Chemistry
QD1-999
Molecular Biology
Spectroscopy
Kynurenine
Cisplatin
reactive oxygen species
Tumor microenvironment
business.industry
Organic Chemistry
General Medicine
NAD
Warburg effect
Computer Science Applications
Mitochondria
Chemistry
030104 developmental biology
Anaerobic glycolysis
Drug Resistance, Neoplasm
030220 oncology & carcinogenesis
Cancer cell
Cancer research
cisplatin resistance
business
Energy Metabolism
metabolism
Oxidation-Reduction
medicine.drug
Subjects
Details
- Language :
- English
- ISSN :
- 14220067
- Volume :
- 22
- Issue :
- 14
- Database :
- OpenAIRE
- Journal :
- International Journal of Molecular Sciences
- Accession number :
- edsair.doi.dedup.....0e5d7668c358d5c5b8ef29b36090d81e